Restricted - initiation by consultant ophthalmologists in the corneal clinic for the treatment of severe keratitis in adult patients with dry eye disease that has not improved despite treatment with tear substitutes in accordance with NICE TA369.
Acetylcysteine 5% with Hypromellose 0.35% (Ilube®)
Hydroxyethylcellulose (Minims® Artificial Tears)
Hydroxypropyl Guar (Systane®)
Hypromellose 0.3% with Dextran 70 0.1% (Tears naturale®)
Liquid Paraffin and Liquid Paraffin light eye drops
Liquid Paraffin eye ointment (Xailin Night®)
Paraffin Yellow Soft
Polyvinyl Alchohol 1.4% (Eye Drops )
Sodium Chloride 0.9% Solutions
Sodium Hyaluronate (Hylo-Forte®)
Sodium Hyaluronate (Lubristil®)
Sodium Hyaluronate (Vismed® Gel)
Sodium Hyaluronate (Vismed® multi)
Soybean oil unit dose eye drops (Emustil®)
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Display tracking information
Link to adult BNF
Link to children's BNF
Link to SPCs
Scottish Medicines Consortium
High Cost Medicine
Cancer Drugs Fund
Traffic Light Status Information
RED - Hospital only – to be prescribed by a specialist and supplied from secondary care ONLY throughout treatment
Amber medicines are considered suitable for GP prescribing following specialist initiation.
These medicines are appropriate for initiation in both primary and secondary care. Prescribing is appropriate within licensed or local recommendations
Shared Care - these medicines require specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and GP by a Shared Care Guideline (SCG). If no SCG in place status reverts to red.
A decision has been made by either or both the local or national NHS not to routinely commission this preparation for its licensed indications. Do not prescribe.